NEWCaplight raises a $16M Series A, led by BlackRock and Fin Capital →
Skip to main content
Caplight Logo









Full-Life Technologies

Full-Life Technologies

Private
ShanghaiHealthcare & Life Scienceshttps://full-life.com/

Last Round

Series D

May 18, 2026

Total Funding Raised

$297.3M

Momentum

Top 10%

of companies Caplight tracks

Company Overview

Full-Life Technologies is a biotechnology company that develops and commercializes precision nuclear medicines and radionuclide-drug conjugates for cancer therapy.

Sector

Healthcare & Life Sciences

Verticals

Biotechnology, Drug Discovery, Precision Medicine, Clinical Trials, Pharma Supply Chain

Business Model

B2B

Customer Profile

Services & Consulting, Revenue Share

AI Layer

Non-AI

Keywords

radiopharmaceuticaltargeted alpha therapyoncologydrug discoveryprecision medicinemetastatic castration-resistant prostate cancermCRPCradioligand therapypharma supply chainclinical trialsbiotechradiolabelingtheranosticsprotein engineeringdrug manufacturing

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

Full-Life Technologies Comps

Public and private peers based on sector, stage, and business model.

Full-Life Technologies comps — public and private peers by sector, stage, and business model
CompanyStatusEst. ValuationRev Multiple
OpenAIPrivate$86.0B~40x
CoherePrivate$5.0B--
Competitor 1Public$XX.XBXXx
Competitor 2Public$XX.XBXXx

View Full Comps Set

Access detailed peer comparisons, multiples, and valuation benchmarks.

Full-Life Technologies Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
Series DMay 18, 2026
Series CSep 30, 2025
DebtSep 30, 2025
DebtJan 3, 2024
Series BJan 3, 2024
Series A
May 26, 2022

Key People

Founding team and executive leadership

Lanny Sun

Chairman & CEO

Executive Team

Full-Life Technologies Investors

Notable investors and investment history

Full-Life Technologies investors
InvestorRounds
CD Capital Asset ManagementSeries A
Summer CapitalSeries C, Series B
Guanghua Wutong FundSeries B
Junson CapitalSeries D, Series C, Series A, Series B
Lapam CapitalSeries C
Yunion Health InvestmentsSeries A
Sky9 CapitalSeries D, Series B

Market signals

Structured signals derived from secondary market and firmographic data.

  • May 18, 2026

    $110M round led by Vivo Capital.

  • Apr 1, 2026

    Job posting reveals development of c-MET assets.

Full-Life Technologies Filings

SEC and related filings with document metadata.

Data table
TypedDateAmount OfferedAmount SoldFillingPagesDownload
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation

Full-Life Technologies Filings

SEC and related filings with document metadata.

Frequently Asked Questions

Common questions about Full-Life Technologies's valuation, stock price, and market status.

Firmographic Details

HeadquartersShanghai
Employee Range69
Year Founded2021
Last FundingMay 18, 2026

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.